Viro - viro - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 50mg 28tk; 50mg 30tk

Viro - viro - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 12,5mg 30tk

Viro - viro - Ravimiamet

teva b.v. - sunitiniib - kõvakapsel - 25mg 28tk

Euroopan unioni - viro - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Viro - viro - Ravimiamet

sandoz pharmaceuticals d.d. - sunitiniib - kõvakapsel - 50mg 30tk

Viro - viro - Ravimiamet

mylan ireland limited - sunitiniib - kõvakapsel - 50mg 28tk

Viro - viro - Ravimiamet

zentiva k.s. - sunitiniib - kõvakapsel - 50mg 28tk; 50mg 30tk

Viro - viro - Ravimiamet

krka, d.d., novo mesto - sunitiniib - kõvakapsel - 50mg 21tk; 50mg 10tk; 50mg 14tk; 50mg 20tk; 50mg 7tk; 50mg 28tk

Viro - viro - Ravimiamet

norameda uab - sunitiniib - kõvakapsel - 50mg 28tk; 50mg 30tk

Viro - viro - Ravimiamet

stada arzneimittel ag - sunitiniib - kõvakapsel - 50mg 30tk; 50mg 28tk